CXCL12 and esophageal squamous cell carcinoma: High pre-treatment levels and increasing post-treatment levels of SDF-1α are independent prognostic factors associated with poor progression-free and overall survival in esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy (31).